MedTrace Logo

An Investigation of the Relationship Between Omega-3 Fatty Acid Nutrition and Mental Health in Children and Adolescents

NCT04158869 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2022-01-11

No results posted yet for this study

Summary

This is an observational case-control add-on study to an investigator-initiated clinical trial (IICT) (ClinicalTrials.gov Identifier: NCT03167307): Omega-3 fatty acids as firstline treatment in pediatric depression. A 36-week multi-centre, double-blind, placebo-controlled randomized superiority study.

This project will recruit a healthy control group matched for age and sex to a sub-group of patients with diagnosed pediatric major depressive disorder (pMDD) enrolled in the IICT. The aim is to investigate the relationship of n-3 FA intake and status with mental health in children and adolescents with and without diagnosed pMDD, and explore potential biochemical mechanisms underlying this relationship by measuring biomarkers related to n-3 FA metabolism, mental health and cognitive function.

Conditions

Sponsors & Collaborators

  • Psychiatric University Hospital, Zurich

    collaborator OTHER

  • Swiss Federal Institute of Technology

    lead OTHER

Principal Investigators

  • Gregor Berger, Dr. med. · Psychiatrische Universitätsklinik Zürich

  • Jeannine Baumgartner, Dr. · Swiss Federal Institute of Technology

  • Isabelle Herter-Aeberli, Dr. · Swiss Federal Institute of Technology

  • Michael B Zimmermann, Dr. med. · Swiss Federal Institute of Technology

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-16
Primary Completion
2020-12-22
Completion
2020-12-22

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04158869 on ClinicalTrials.gov